Revenue Source Policy

Revenue Source Policy

TMP Universal Journal of Advances in Pharmaceutical Sciences operates with a focus on providing open access to high-quality research in pharmaceutical sciences. To maintain the sustainability of the journal and ensure that it continues to provide free access to its content, we have a transparent revenue model in place. Below is an outline of our revenue sources.

  1. Open Access Model

As a fully open access journal, all articles published in TMP Universal Journal of Advances in Pharmaceutical Sciences are freely available to readers worldwide. The journal does not charge any fees for submission, peer review, or publication of articles, ensuring accessibility to research without financial barriers.

  1. Publisher's Revenue Sources

The primary source of revenue for the journal comes from the following:

  • Institutional Subscriptions: Some institutions, libraries, and universities may opt for institutional subscriptions for access to journal archives or special services. These subscriptions help support the journal's operational costs.
  • Advertising: The journal may display relevant advertisements from trusted third-party companies or institutions related to pharmaceutical sciences, research tools, or educational content. All advertisements are subject to editorial review and must adhere to ethical guidelines, ensuring no conflict with the journal’s academic integrity.
  • Sponsorships: The journal may enter into sponsorship agreements with pharmaceutical companies, research organizations, or academic institutions. Sponsors may support specific issues, events, or special editions, such as conference proceedings or thematic issues. All sponsorships are disclosed, and sponsors have no influence over the editorial content or decisions.
  • Optional Services: Although the journal does not charge for publication, there may be fees for optional services such as article promotion, language editing, and additional print copies. These services are optional and not mandatory for publication.
  • Grants and Donations: The journal may also seek grants or donations from academic foundations, government bodies, or research institutions to support its operational costs and continue offering high-quality open access content. These grants will be used solely to enhance the journal’s quality and accessibility.
  1. No Article Processing Charges (APCs)

TMP Universal Journal of Advances in Pharmaceutical Sciences operates without Article Processing Charges (APCs) for authors. Authors are not required to pay any fees for submitting or publishing their manuscripts. This policy ensures that the journal remains accessible to researchers from diverse backgrounds and institutions, regardless of financial constraints.

  1. Transparency in Revenue

The journal is committed to transparency in its revenue generation practices. Any funding received through sponsorships, institutional subscriptions, or advertising will be clearly stated in the journal's publications. Authors, readers, and other stakeholders can expect full transparency regarding how the revenue is used to maintain the quality and accessibility of the journal.

  1. Ethical Revenue Generation

The journal ensures that all revenue sources adhere to ethical guidelines and do not influence editorial decisions. We prioritize academic integrity and impartiality in the publication process. Revenue generation activities, including advertising and sponsorships, are reviewed by the editorial team to ensure that they align with the journal’s mission and ethical standards.

  1. Reinvestment in the Journal

Any revenue generated by the journal will be reinvested to support the following activities:

  • Improving the editorial and peer review process
  • Enhancing website functionality and user experience
  • Supporting the publication of special issues or thematic collections
  • Funding outreach and promotion activities to increase the journal’s visibility
  • Maintaining high-quality standards in the publication process